Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C14H19NO2 |
| Molecular Weight | 233.3062 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC=C(C=C1)C(=O)C(C)N2CCCC2
InChI
InChIKey=QJWOQBGBEFNYKB-UHFFFAOYSA-N
InChI=1S/C14H19NO2/c1-11(15-9-3-4-10-15)14(16)12-5-7-13(17-2)8-6-12/h5-8,11H,3-4,9-10H2,1-2H3
| Molecular Formula | C14H19NO2 |
| Molecular Weight | 233.3062 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 10:29:17 UTC 2023
by
admin
on
Sat Dec 16 10:29:17 UTC 2023
|
| Record UNII |
OI15TPX8QP
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs-MOPPP
Created by
admin on Sat Dec 16 10:29:17 UTC 2023 , Edited by admin on Sat Dec 16 10:29:17 UTC 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID701023585
Created by
admin on Sat Dec 16 10:29:17 UTC 2023 , Edited by admin on Sat Dec 16 10:29:17 UTC 2023
|
PRIMARY | |||
|
6430836
Created by
admin on Sat Dec 16 10:29:17 UTC 2023 , Edited by admin on Sat Dec 16 10:29:17 UTC 2023
|
PRIMARY | |||
|
478243-09-3
Created by
admin on Sat Dec 16 10:29:17 UTC 2023 , Edited by admin on Sat Dec 16 10:29:17 UTC 2023
|
PRIMARY | |||
|
4'-Methoxy-α-pyrrolidinopropiophenone
Created by
admin on Sat Dec 16 10:29:17 UTC 2023 , Edited by admin on Sat Dec 16 10:29:17 UTC 2023
|
PRIMARY | MOPPP use is infrequent when compared to other amphetamines or stimulants used recreationally, such as meth, cocaine, or speed. It first arose as a designer drug in Germany in the late 1990s and early 2000s, along with a number of other derivatives but never gained the international popularity[4][5] that other drugs in its family of pyrrolidinophenone derivatives had (such as α-PPP and MDPV). | ||
|
OI15TPX8QP
Created by
admin on Sat Dec 16 10:29:17 UTC 2023 , Edited by admin on Sat Dec 16 10:29:17 UTC 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
